Yes, you can sell a private label ectoin serum in both markets, but the regulatory pathway diverges meaningfully after the formula is finalized, and conflating the two compliance tracks is a common and expensive mistake for emerging brands.
In the United States, ectoin serums are regulated as cosmetics under FDA's FD&C Act as updated by MoCRA (2022). Your obligations as the brand owner include ensuring your manufacturer is FDA-registered, listing your product with FDA (MoCRA product listing is now mandatory for most cosmetics), ensuring the label meets 21 CFR requirements (ingredients in descending order by predominance, net quantity, name and place of business, required warnings), and not making drug claims. There is no pre-market approval — you are responsible for ensuring your product is safe before it goes on sale.
In the European Union, ectoin serums fall under EU Cosmetics Regulation 1223/2009. The critical difference from the US system is the requirement for a designated Responsible Person (RP) — a legal entity established in the EU who takes regulatory accountability for the product. If you are a US brand, you must appoint an EU-based RP before you can legally sell in any EU member state. The RP must compile a Product Information File (PIF) containing the formula, INCI list, stability data, PET data, and a Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor. Products must also be notified via the EU Cosmetic Products Notification Portal (CPNP). Ectoin is not on the EU's restricted or prohibited lists, so there are no additional substance-specific hurdles.
Post-Brexit, the UK operates its own cosmetics regulation (UK Cosmetics Regulation, which mirrors the EU regulation with UK-specific modifications). You need a UK Responsible Person separately from your EU RP, and UK product notification goes through the Office for Product Safety and Standards (OPSS) portal. If you're launching in both EU and UK, budget for two RP arrangements.
The practical implication for manufacturer selection: your manufacturing partner should be able to supply the documentation package (full formula with percentages, raw material CoAs, stability data, PET report, safety data sheets) that your EU and UK safety assessors need. Ask explicitly whether they have previously supported EU CPSR preparation for other clients — many low-MOQ US manufacturers have not, and the gap in their documentation will slow your EU launch considerably.
AJ Cosmo Labs includes manufacturers who operate across multiple regulatory jurisdictions, and supplier profiles indicate which markets their client products are currently sold in — a useful proxy for regulatory capability.
Read the full guide on Private Label Ectoin Serum Manufacturer Low MOQ →